Neuropsychopharmacology
- Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial1 year ago
- Aversion-induced dopamine reductions predict drug-taking and escape behaviors1 year ago
- Heritable consequences of paternal heroin use: a role for miR-19b in drug-taking behavior1 year ago
- Correction: Lateral habenula induces cognitive and affective dysfunctions in mice with neuropathic pain via an indirect pathway to the ventral tegmental area1 year ago
- Neighborhood social fragmentation in relation to impaired mismatch negativity among youth at clinical high risk for psychosis and healthy comparisons1 year ago
- Random forest and Shapley Additive exPlanations predict oxytocin targeted effects on brain functional networks involved in salience and sensorimotor processing, in a randomized clinical trial in autism1 year ago
- Abnormal ventromedial-to-dorsolateral hierarchical topography of striatal circuits in cocaine use disorder and its modulations by brain stimulation1 year ago
Journal of Psychopharmacology
- Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial3 years ago
- Modafinil: A closer look at its theoretical toxicological potential3 years ago
- Science, safety and education: Informing the psychedelic treatment of psychiatric disorders3 years ago
- Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review3 years ago
- Oral sodium oxybate does not alter plasma kisspeptin levels in healthy male volunteers3 years ago
- Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice3 years ago
- Psilocybin’s effects on cognition and creativity: A scoping review3 years ago
European Neuropsychopharmacology
- A maturational shift in the frontal cortex synaptic transcriptional landscape underlies schizophrenia-relevant behavioural traits: A congenital rat model3 years ago
- Technology exceptionalism in medicine: Is it time to rethink the paradigm?3 years ago
- Disease progression to bipolar disorder among adolescents and young adults with antidepressant-resistant and antidepressant-responsive depression: Does antidepressant class matter?3 years ago
- Comparing the pharmacology and pharmacokinetics of antipsychotics: Choosing an antipsychotic and dosing a long-acting injectable3 years ago
- Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice3 years ago
- Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study3 years ago
- Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis3 years ago